Trial intelligence / Profile preview

Immune Persistence of Live Attenuated Varicella Vaccine in Children

NCT01982409Phase 4Unknown

Sponsor
Changchun Changsheng Biological Products
Start
Jun 2013
Primary completion
Jan 2018
Modality
Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
Countries
1
01

Overview

A Phase 4 trial of varicella vaccine live attenuated in chickenpox, sponsored by Changchun Changsheng Biological Products. Status: unknown.

02

Drugs

varicella vaccine live attenuated
03

Conditions

chickenpox

Beyond the preview

Go deeper on NCT01982409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01982409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call